Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Medical Optics and Ophtec to work on new phakic IOL (intraocular lens):

This article was originally published in Clinica

Executive Summary

Advanced Medical Optics (AMO) and Ophtec are to collaborate on the design and regulatory approval strategy of Veriflex, a new foldable version of the Verisyse phakic intraocular lens (IOL) for which AMO holds global distribution rights. Under a similar agreement for Veriflex, AMO will be the exclusive distributor of the lens in the US, Japan and Europe. Both the Veriflex and Verisyse phakic IOLs are designed for implantation in patients whose refractive errors cannot be corrected by current refractive surgical methods such as LASIK. The Verisyse, already available in Europe, is currently awaiting the final green light from the FDA after having received approval recommendation from the ophthalmic devices panel in February this year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058680

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel